It mainly includes remodeling immunosuppressive cells (such as TAMs, MDSCs and Tregs), reactivating immune effector cells (T cells and NK cells), and modulating TGF-β-related signaling pathways in glioma cells. This evidence concerns the gene TGFB1 and central nervous system cancer.